研究住院COVID-19老年患者的风险因素,临床概况和结果
1Internal Medicine and Geriatrics, Medanta the Medicity Hospital, Gurgaon, Haryana, India.
Journal of family medicine and primary care
|October 3, 2025
概括
这项研究分析了住院老年患者的COVID-19结果,发现年龄和并发症显著影响疾病严重程度和ICU入院. 早期干预和特定治疗可以减少住院时间.
科学领域:
- 老年学是一门学科.
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 冠状病毒,包括SARS,MERS和COVID-19,导致呼吸系统疾病.
- 首次在中国武汉发现的COVID-19导致了全球卫生危机.
- 了解COVID-19的流行病学和风险因素对于有效的公共卫生反应至关重要.
研究的目的:
- 调查COVID-19的住院老年患者 (>60岁) 的风险因素,临床概况和结果.
- 在不同老年人年龄组中,将疾病严重程度与并发症,实验室和放射学参数相关联.
- 在COVID-19大流行期间确定早期干预和资源分配的高风险群体.
主要方法:
- 2020年4月至12月,对住院的老年COVID-19患者 (年龄超过60岁) 进行了回顾性观察研究.
- 数据收集包括临床病史,并发症,症状,治疗和住院 (包括ICU).
- 年轻老年人 (60-70岁),老年人 (71-80岁) 和非常老年人 (>81岁) 群体之间的结果比较.
主要成果:
- 患有COVID-19的老年患者 (>60) 在各年龄组 (年轻人,老年人,非常老年人) 显示出不同的分布.
- 高血压,糖尿病,甲状腺功能低下和CAD是普遍存在的并发症.
- 发烧,上呼吸道感染和呼吸短促是常见的症状; 随着年龄和并发性疾病的增加,ICU的入院人数增加.
结论:
- 老年人是严重COVID-19的脆弱群体,并发症增加和ICU入院与年龄和并发症相关.
- 抗病毒治疗,如雷姆迪西维尔和治疗,如血和托西利祖马布显示潜在的减少住院时间.
- 临床参数,如费里丁,CRP,D-二次数,淋巴细胞减少和CTSS的升高,是老年COVID-19患者疾病严重程度的重要指标.
相关概念视频
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
187
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
187
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
232
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
232
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
196
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
196
01:15Drug Dosing: Geriatric Patients
225
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
225
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
234
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
234
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
227
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
227